Research Leaders / KOL Map

NASH / MASH: Research Leaders and Landscape

The most active researchers, institutions, and subtopics in NASH / MASH, from recent PubMed records. Public authorship only, every figure verifiable by PMID.

Analyzed 600 recent PubMed papers (2021-2026) matching "MASH OR nonalcoholic steatohepatitis resmetirom liver". Source: NLM PubMed. Generated July 2026.

Top research leaders (by recent publication volume)

#ResearcherAffiliationPapers
1El-Kassas MohamedCapital University (Formerly Helwan University)10
2Loomba RohitUniversity of California at San Diego10
3Tacke FrankCharité - Universitätsmedizin Berlin9
4Zelber-Sagi ShiraUniversity of Haifa8
5Yu Ming-LungKaohsiung Medical University Hospital7
6Henry LindaThe Global NASH/MASH Council7
7Stepanova MariaThe Global NASH/MASH Council7
8Wong Vincent Wai-SunThe Chinese University of Hong Kong7
9Eguchi YuichiroThe Global NASH/MASH and Global Liver Councils6
10Spearman C WendyUniversity of Cape Town6
11Noureddin MazenHouston Methodist Hospital6
12Targher GiovanniUniversity of Verona5
13Chalasani NagaIndiana University School of Medicine5
14Krag AleksanderOdense University Hospital5
15Papatheodoridis GeorgeMedical School of National and Kapodistrian University of 5
16Yilmaz YusufRecep Tayyip Erdoğan University5
17Nader FatemaThe Global NASH/MASH Council5
18Zheng Ming-HuaThe First Affiliated Hospital of Wenzhou Medical Universit5

Ranked by recent publication volume; names not yet disambiguated and not citation-weighted. The full brief adds ORCID disambiguation, citation weighting, and clinical-trial investigator data.

Leading institutions

College of Medicine (13), Mayo Clinic (13), University of California San Diego (12), Virginia Commonwealth University School of Medicine (11), The Global NASH/MASH Council (11), University of California (10), The Chinese University of Hong Kong (10), Cleveland Clinic (8), College of Pharmacy (7), Saarland University Medical Center (7)

Active subtopics

Fatty Liver (171), Liver (109), Mice (98), Non-alcoholic Fatty Liver Disease (90), Mice, Inbred C57BL (72), Liver Cirrhosis (57), Disease Models, Animal (45), Signal Transduction (41)

Top journals

Scientific reports (15), Clinics in liver disease (15), JHEP reports : innovation in hepatology (14), Liver international : official journal of the International Association for the Study of the Liver (13), Biomedicines (10), Journal of hepatology (10)

Representative recent papers

A precision-constrained framework for evaluating noninvasive biomarkers in MASLD and beyond. (2026) · PMID 42477328

Exploring the Effect of Gender Norms on Provider-Client Interactions Relevant to HIV Care Engagement: A Qualitative Study in Ugand (2026) · PMID 42477248

BD1-biased BET inhibition attenuates TXNIP-associated inflammation in diabetic MASH. (2026) · PMID 42475798

Metabolic-Dysfunction Associated Steatotic Liver Disease (MASLD) in Children - A Review For Primary Care Pediatrics. (2025) · PMID 42475149

Revisiting cannabinoid receptor-2: a key regulator of hepatic steatosis, inflammatory cascades, and fibrotic progression. (2026) · PMID 42474488

Want the full cited brief?

A full NASH / MASH brief adds citation weighting, name disambiguation, clinical-trial investigators, and a cited PDF, scoped to your exact molecule, competitor set, or region.

Try the live tool Contact us